Physician profile
Andrew E Caputo
NPI 1871590190
$841.32
in general payments reported to CMS, 2019-2025
12 companies · $69.83 in 2025
The $69.83 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $124 · 2021: $15.06 · 2022: $14.39 · 2023: $162 · 2024: $181 · 2025: $69.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $145.78 | 2024 | Ceramentbone Void Filler, Cerament G |
| Acumed LLC | $145.44 | 2023 | Acumed, Inframe Implant |
| Horizon Therapeutics Plc | $137.94 | 2019-2021 | |
| Wright Medical Technology, INC. | $115.24 | 2019 | |
| Amniox Medical, INC. | $102.51 | 2019 | |
| Depuy Synthes Sales INC. | $69.83 | 2025 | Unium |
| Aap Implants INC | $43.99 | 2019 | |
| Pfizer INC. | $20.63 | 2024 | |
| Smith+Nephew, INC. | $16.75 | 2023 | Pico 14 |
| Bioventus LLC | $14.59 | 2024 | Exogen Ultrasound Bone Healing System |
| Kowa Pharmaceuticals America, INC. | $14.39 | 2022 | |
| Axogen | $14.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Caputo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.